Finally, two more proteins were found to be upregulated upon treatment: sarcoglycan delta (SGCD) and serum response factor binding protein 1 (SRFBP1), usually downregulated or mutated in hypertrophic and dilated cardiomyopathies and during heart failure, respectively [50,51]. This evidence concerns the gene SRFBP1 and heart failure.